Autopsy report · NCT00676871

A Study to Evaluate the Safety, Tolerability, and Antitumor Activity of Continuous Intravenous Infusion of MEDI-538 in Adults With B-Cell Chronic Lymphocytic Leukemia (CLL)

“Replacing this trial with a new trial.”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Phase 1, Phase 2

Sponsor

MedImmune LLC

Sponsor type

Industry

Conditions

Chronic Lymphocytic Leukemia

Interventions

MEDI-538; MEDI-538; MEDI-538; MEDI-538; MEDI-538; MEDI-538

Participants

30 (planned, not actual)

Trials that died the same way

• A Study to Evaluate the Efficacy and Safety of Liso-cel Compared to Standard of Care in Adults With Relapsed or Refractory Follicular Lymphoma
  “Replaced with another clinical trial.” (78% match in meaning)
• A Phase 1b Proof-of-concept Trial Exploring the Effects of FE 999322 and FE 999324 in Adults With Mild to Moderate Ulcerative Colitis
  “Not due to safety concerns, but changes in strategy which this trial no longer fulfills.” (65% match in meaning)
• Clinical Study of Pulsed, Inhaled Nitric Oxide Versus Placebo in Symptomatic Subjects With PAH
  “Trial stopped for futility” (63% match in meaning)
• Compare Technegas Ventilation-Perfusion SPECT and Xenon Ventilation-Perfusion Planar Imaging for Pulmonary Embolism
  “Decision to change trial design.” (62% match in meaning)
• Hantavirus Transmission in Households in Chile
  “This is not a clinical trial and was inadvertently added to the system.” (61% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.